Chester Hendershot, PA
Physician Assistant · Tulsa, OKNPI 1326553256
Payments from drug & device makers
Across 268 payments — averaging $13.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$768
- Takeda Pharmaceuticals U.S.A., Inc.$275
- Bausch Health US, LLC$242
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$225
- Lundbeck LLC$219
- Otsuka America Pharmaceutical, Inc.$211
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,46698%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $768 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $275 |
| Bausch Health US, LLC | 13 | $242 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $225 |
| Lundbeck LLC | 13 | $219 |
| Otsuka America Pharmaceutical, Inc. | 26 | $211 |
| Sunovion Pharmaceuticals Inc. | 10 | $203 |
| Eisai Inc. | 11 | $174 |
| Merck | 11 | $156 |
| Avanir Pharmaceuticals, Inc. | 10 | $153 |
| Jazz Pharmaceuticals Inc. | 8 | $150 |
| Adlon Therapeutics L.p. | 11 | $123 |
| Orexo US, Inc. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 6 | $97 |
| Biohaven Pharmaceuticals, Inc. | 4 | $77 |
| Neurocrine Biosciences, Inc. | 5 | $76 |
| Indivior Inc. | 4 | $64 |
| Corium, LLC | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Johnson & Johnson | 2 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $13 |
How this compares
$3,523 in reported general payments places this provider in the 85th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 12 | $354 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $220 |
| Cephalexin | 32 | $199 |
| Methylprednisolone | 24 | $168 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $133 |
| Azithromycin | 37 | $117 |
| Prednisone | 49 | $84 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Tulsa
- Matthew PattonTulsa$24K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
- Jenny BirksTulsa$13K
- Andrea BellassaiTulsa$12K
- Jennifer ComptonTulsa$12K
- Adrian DonnellyTulsa$12K
- Valerie TerrellTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.